St. Francis Cancer Center | St. Francis Cancer Center | NSABP B-55
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1152
clinical-trial-template-default,single,single-clinical-trial,postid-1152,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

NSABP B-55

 A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy   Read More>

« Available Clinical Trials